Veterans Affairs, Department Of- Veterans Affairs, Department Of- Nac Pharmaceuticals ( 36e797) - Agency Bids & RFPs

Offers are due by 2:30 PM CT on June 11, 2026. Proposals should be submitted well before the deadline and receipt confirmed with the contracting officer.

Payment will be made by EFT. Invoices should be submitted according to business-to-business agreements with prime vendors, as the government is not a party to these agreements.

The contractor warrants that the items delivered are merchantable and fit for the particular purpose described in the contract.

Offers will be evaluated in accordance with the policies and procedures of FAR Part 12, Part 15, and Part 25. One award will be made for all line items for the base year and all four option years.

Offerors must submit a price for the base year and all four option years for all line items. Distributors must submit a letter of commitment from the manufacturer. Manufacturing facilities must have acceptable CGMP status with the FDA.

Failure to provide awarded product meeting all solicitation/contract requirements by the ordering period start date may result in contract termination for cause. Willful failure or refusal to furnish required reports or falsification thereof shall constitute sufficient cause for terminating the contract.

Proposals that fail to include a price for the base year and each of the four option years may be rejected. Failure to maintain an agreement with prime vendors throughout the contract period may result in termination for cause.

The ordering period begins at the expiration of the implementation period. The base year ordering period will be in effect for one year. The contractor shall not be required to make any deliveries under this contract after 15 calendar days from the expiration date of the contract.

Contractors will be receiving payments from the PPV programs instead of directly from the government. The contractor shall submit invoices in accordance with the businesstobusiness agreements reached with the PPV programs.

The contractor warrants and implies that the items delivered under this contract are merchantable and fit for use for the particular purpose described in this contract.

One award will be made for line item 1. To be considered for award, offerors must submit a price for the base year and all four one-year options for all line items.

Offerors must submit a letter of commitment from the manufacturer if they are not the manufacturer. Manufacturing facilities must have an acceptable CGMP status with the FDA. Only offers from companies that have an acceptable CGMP status on record with the FDA for the facilities identified by the offeror in section 13. 7 below will be considered for award.

Failure to provide awarded product meeting all solicitation/contract requirements by the ordering period start date may result in contract termination for cause. Willful failure or refusal to furnish the required reports, or falsification thereof, shall constitute sufficient cause for terminating the contract.

Proposals that fail to include a price for the base year and each of the four option years may be rejected. Failure to provide an acceptable subcontracting plan may result in contract termination. Failure or refusal to reach agreement with the PPVs and maintain an agreement with the PPVs throughout the entire contract period shall constitute sufficient cause for terminating the contract.

The offer due date is June 11, 2026, at 2:30 PM CT. Proposals must be submitted via email and confirmation of receipt is recommended.

Payment will be made by EFT. Contractors will receive payments from Prime Vendor contractors, not directly from the government. Invoices are submitted according to business-to-business agreements with Prime Vendors.

The contractor warrants that the items delivered are merchantable and fit for use for the particular purpose described in the contract.

Offerors must submit a price for the base year and all four option years. If not the manufacturer, a letter of commitment from the manufacturer is required. Manufacturing facilities must have acceptable CGMP status with the FDA.

Failure to provide awarded product by the ordering period start date may result in contract termination for cause. Willful failure or refusal to furnish required reports or falsification thereof may result in contract termination for cause.

Proposals that fail to include a price for the base year and each of the four option years may be rejected. Offers that fail to provide the required NDC number information may be rejected.

The bid notice does not specify the award criterion.

The bid notice states the award amount is $5,939,****.